A. Nagel

1.5k citations

34 papers · 997 indexed · 1 hit paper · h-index 14

Organic Chemistry top 5%
Molecular Biology
Pharmacology top 5%
Spectroscopy top 10%
Computational Theory and Mathematics top 10%

Co-authors: Lawrence A. Vincent H. C. VAN DER PLAS Ernest Wenkert Brian L. Buckwalter Ferdinand Näf Terry Rosen Stafford McLean Samuel J. Danishefsky
Topics: Synthesis and Biological Evaluation (6 papers)Synthesis and Reactions of Organic Compounds (6 papers)Chemical synthesis and alkaloids (4 papers)
Cited by: Organic Chemistry Pharmacology Biochemistry
Journals: Journal of the American Chemical Society Journal of Medicinal Chemistry Antimicrobial Agents and Chemotherapy
Partner nations: United States Netherlands Switzerland

In The Last Decade

A. Nagel

34 papers receiving 918 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Macrolide antibiotics. Chemistry, biology, and practice

1985 418 citations A. Nagel Journal of Pharmaceutical Sciences profile →

Peers

Countries citing papers authored by A. Nagel

Since Specialization

Citations

This map shows the geographic impact of A. Nagel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Nagel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Nagel more than expected).

Fields of papers citing papers by A. Nagel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Nagel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Nagel. The network helps show where A. Nagel may publish in the future.

Co-authorship network of co-authors of A. Nagel

This figure shows the co-authorship network connecting the top 25 collaborators of A. Nagel. A scholar is included among the top collaborators of A. Nagel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Nagel. A. Nagel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Diastereoselective Synthesis of 2,3,6-Trisubstituted Piperidines 2009 ·The Journal of Organic Chemistry ·John M. Humphrey,Eric P. Arnold,Thomas A. Chappie,John B. Feltenberger,A. Nagel,(unknown),(unknown),Norma J. Tom,Brian T. O’Neill	15
2	2‐Amino‐4‐methylpyridine as a potent inhibitor of inducible NO synthase activity in vitro and in vivo 1996 ·British Journal of Pharmacology ·W. Stephen Faraci,A. Nagel,(unknown),Lawrence A. Vincent,Hong Xu,(unknown),(unknown),E.D. Salter,E. R. Pettipher	53
3	5,7-Dihydro-3-[2-[1-(phenylmethyl)-4-piperidinyl]ethyl]-6H-pyrrolo[3,2-f]-1,2-benzisoxazol-6-one: A Potent and Centrally-Selective Inhibitor of Acetylcholinesterase 1995 ·Journal of Medicinal Chemistry ·(unknown),Todd W. Butler,Douglas S. Chapin,(unknown),(unknown),Jeffrey L. Ives,Susan B. Jones,Dane Liston,A. Nagel	36
4	ChemInform Abstract: 5,7‐Dihydro‐3‐(2‐(1‐(phenylmethyl)‐4‐piperidinyl)ethyl)‐6H‐pyrrolo(3,2‐ f)‐1,2‐benzisoxazol‐6‐one: A Potent and Centrally‐Selective Inhibitor of Acetylcholinesterase with an Improved Margin of Safety. 1995 ·ChemInform ·(unknown),Todd W. Butler,Douglas S. Chapin,(unknown),(unknown),Jeffrey L. Ives,Shawn B. Jones,Dane Liston,A. Nagel,Deane M. Nason,J.A. Nielsen,Antonio Ramı́rez,Ismail A. Shalaby,William F. White	3
5	Design and Synthesis of 1-Heteroaryl-3-(1-benzyl-4-piperidinyl)propan-1-one Derivatives as Potent, Selective Acetylcholinesterase Inhibitors 1995 ·Journal of Medicinal Chemistry ·A. Nagel,Dane Liston,(unknown),(unknown),Lawrence A. Vincent,Douglas S. Chapin,Yuhpyng L. Chen,(unknown),Jeffrey L. Ives	38
6	1-Naphthylpiperazine derivatives as potential atypical antipsychotic agents 1991 ·Journal of Medicinal Chemistry ·John Lowe,Thomas Seeger,A. Nagel,(unknown),Patricia A. Seymour,James Heym,Frank E. Ewing,Michael Newman,Anne W. Schmidt	36
7	Novel in vitro and in vivo inhibitors of prolyl endopeptidase 1991 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),(unknown),(unknown),Lawrence A. Vincent,A. Nagel,Robin W. Spencer,Fredric J. Vinick,W. Stephen Faraci	7
8	ChemInform Abstract: 1‐Naphthylpiperazine Derivatives as Potential Atypical Antipsychotic Agents. 1991 ·ChemInform ·John Lowe,Thomas Seeger,A. Nagel,Harry Howard,P A Seymour,James Heym,Frank E. Ewing,Michael E. Newman,Anne W. Schmidt,(unknown),Lawrence A. Vincent,Patrick Maloney,(unknown),L S Reynolds,Fredric J. Vinick	1
9	An initial three-component pharmacophore for specific serotonin-3 receptor ligands 1990 ·Journal of Medicinal Chemistry ·James P. Rizzi,A. Nagel,Terry Rosen,Stafford McLean,Thomas Seeger	40
10	Thiazole as a carbonyl bioisostere. A novel class of highly potent and selective 5-HT3 receptor antagonists 1990 ·Journal of Medicinal Chemistry ·Terry Rosen,A. Nagel,(unknown),Jeffrey L. Ives,(unknown),Alan H. Ganong,(unknown),James Heym,Stafford McLean	29
11	Aromatic thiazole derivatives: structurally novel and selective serotonin-3 receptor antagonists 1990 ·Journal of Medicinal Chemistry ·A. Nagel,Terry Rosen,James P. Rizzi,(unknown),(unknown),(unknown),Lawrence A. Vincent,James Heym,Stafford McLean	35
12	Synthesis, in vitro binding profile, and CNS penetrability of the highly potent 5-HT3 receptor antagonist [3H]-4-(2-methoxyphenyl)-2-[4(5)-methyl-5(4)-imidazolylmethyl]thiazole 1990 ·Journal of Medicinal Chemistry ·Terry Rosen,Thomas Seeger,Stafford McLean,A. Nagel,Jeffrey L. Ives,(unknown),David L. Bryce,J. M. Furman,(unknown)	5
13	Synthese von Fluoro‐λ⁵‐monophosphazenen und Fluoro‐1, 3‐diaza‐2λ⁵, 4λ⁵‐diphosphetidinen mittels der Staudinger‐Reaktion 1986 ·Zeitschrift für anorganische und allgemeine Chemie ·L. Riesel,(unknown),A. Nagel,(unknown),(unknown),(unknown)	11
14	Macrolide antibiotics. Chemistry, biology, and practicebreakdown → 1985 ·Journal of Pharmaceutical Sciences ·A. Nagel	418
15	Synthesis and biological activities of 4"-deoxy-4"-sulfonamido-oleandomycin derivatives 1984 ·Antimicrobial Agents and Chemotherapy ·G. Michael Bright,A. R. English,A. Nagel,James A. Retsema,(unknown)	3
16	t-butylation of quinazoline 1979 ·Tetrahedron Letters ·D. A. DE BIE,A. Nagel,H. C. VAN DER PLAS,Gert J. Geurtsen,Arie Koudijs	2
17	Selective cleavage of the mycinose sugar from the macrolide antibiotic tylosin: a unique glycosidic scission 1979 ·The Journal of Organic Chemistry ·A. Nagel,Lawrence A. Vincent	6
18	On the mechanism of the conversion of 6‐chloropyrido[2,3‐B]pyrazine into 1h‐lmidazo[4,5‐b] pyridine by potassium amide in liquid ammonia 1979 ·Journal of Heterocyclic Chemistry ·A. Nagel,H. C. VAN DER PLAS,Gert J. Geurtsen,(unknown)	3
19	¹H NMR studies of σ‐adducts of pteridine and some of its derivatives in liquid ammonia 1975 ·Recueil des Travaux Chimiques des Pays-Bas ·A. Nagel,H. C. VAN DER PLAS,A. van Veldhuizen	19
20	A ready synthesis of (±)-D-homo-oestrone 1972 ·Journal of the Chemical Society Chemical Communications ·Samuel J. Danishefsky,A. Nagel	6

About A. Nagel

A. Nagel is a scholar working on Organic Chemistry, Pharmaceutical Science and Pharmacology, having authored 34 papers that have together received 997 indexed citations. Recurring topics across this work include Synthesis and Biological Evaluation (6 papers), Synthesis and Reactions of Organic Compounds (6 papers) and Chemical synthesis and alkaloids (4 papers). The work is most often cited by research in Organic Chemistry (508 citations), Pharmacology (231 citations) and Biochemistry (58 citations). A. Nagel has collaborated with scholars based in United States, Netherlands and Switzerland. Frequent co-authors include Lawrence A. Vincent, H. C. VAN DER PLAS, Ernest Wenkert, Brian L. Buckwalter, Ferdinand Näf, Terry Rosen, Stafford McLean, Samuel J. Danishefsky, James P. Rizzi and Thomas Seeger. Their work appears in journals such as Journal of the American Chemical Society, Journal of Medicinal Chemistry and Antimicrobial Agents and Chemotherapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact